Angiopoietin-like 4 regulates epidermal differentiation

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Pal, Mintu ^a   Tan, Ming Jie ^a   Huang, Royston Luke ^a   Goh, Yan Yih ^a   Wang, Xiao Ling ^a   Tang, Mark Boon Yang ^b   Tan, Nguan Soon ^a  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^b NATIONAL SKIN CENTRE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

[2 METHYL 4 [4 METHYL 2 (4 TRIFLUOROMETHYLPHENYL) 5 THIAZOLYLMETHYLTHIO]PHENOXY]ACETIC ACID; ANGIOPOIETIN; ANGIOPOIETIN LIKE 4; CARBOXY TERMINAL TELOPEPTIDE; FIBRINOGEN; GSK 0660; INVOLUCRIN; MONOCLONAL ANTIBODY; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ANTAGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PROTEIN C JUN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 1; PROTEIN KINASE C; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR JUNB; UNCLASSIFIED DRUG; ANGPTL4 PROTEIN, HUMAN; ANGPTL4 PROTEIN, MOUSE; PROTEIN PRECURSOR; THIAZOLE DERIVATIVE; TRANSGLUTAMINASE 1;

ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; EPIDERMIS CELL; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; KERATINOCYTE; MALE; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SKIN BIOPSY; SKIN CULTURE; WILD TYPE; ANIMAL; CELL CULTURE; CHROMATIN IMMUNOPRECIPITATION; CYTOLOGY; DRUG EFFECT; DRUG POTENTIATION; EPIDERMIS; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; IMMUNOBLOTTING; METABOLISM; MICROBIOLOGY; MOUSE MUTANT; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION;

MUS;

ANGIOPOIETINS; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; EPIDERMIS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOBLOTTING; KERATINOCYTES; MICE; MICE, KNOCKOUT; PPAR DELTA; PPAR-BETA; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN PRECURSORS; REAL-TIME POLYMERASE CHAIN REACTION; THIAZOLES; TRANSGLUTAMINASES;

EID: 80053056171     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025377     Document Type: Article

References (41)

1. Dotto GP, (1999) Signal transduction pathways controlling the switch between keratinocyte growth and differentiation. Crit Rev Oral Biol Med 10: 442-457.
2. Eckert RL, Crish JF, Robinson NA, (1997) The epidermal keratinocyte as a model for the study of gene regulation and cell differentiation. Physiol Rev 77: 397-424.
3. Eckert RL, Welter JF, (1996) Transcription factor regulation of epidermal keratinocyte gene expression. Mol Biol Rep 23: 59-70.
4. Hanley K, Devaskar UP, Hicks SJ, Jiang Y, Crumrine D, et al. (1997) Hypothyroidism delays fetal stratum corneum development in mice. Pediatr Res 42: 610-614.
5. Kömüves LG, Hanley K, Jiang Y, Elias PM, Williams ML, et al. (1998) Ligands and activators of nuclear hormone receptors regulate epidermal differentiation during fetal rat skin development. J Invest Dermatol 111: 429-433.
6. Michalik L, Desvergne B, Tan NS, Basu-Modak S, Escher P, et al. (2001) Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR)alpha and PPARbeta mutant mice. J Cell Biol 154: 799-814.
7. Tan NS, Michalik L, Noy N, Yasmin R, Pacot C, et al. (2001) Critical roles of PPAR beta/delta in keratinocyte response to inflammation. Genes Dev 15: 3263-3277.
8. Tan NS, Michalik L, Desvergne B, Wahli W, (2003) Peroxisome proliferator-activated receptor (PPAR)-beta as a target for wound healing drugs: what is possible? Am J Clin Dermatol 4: 523-530.
9. Tan NS, Michalik L, Desvergne B, Wahli W, (2004) Peroxisome proliferator-activated receptor-beta as a target for wound healing drugs. Expert Opin Ther Targets 8: 39-48.
10. Schmuth M, Haqq CM, Cairns WJ, Holder JC, Dorsam S, et al. (2004) Peroxisome proliferator-activated receptor (PPAR)-beta/delta stimulates differentiation and lipid accumulation in keratinocytes. J Invest Dermatol 122: 971-983.
11. Tan NS, Icre G, Montagner A, Bordier-ten-Heggeler B, Wahli W, et al. (2007) The nuclear hormone receptor peroxisome proliferator-activated receptor beta/delta potentiates cell chemotactism, polarization, and migration. Mol Cell Biol 27: 7161-7175.
12. Tan NS, Michalik L, Desvergne B, Wahli W, (2005) Genetic- or transforming growth factor-beta 1-induced changes in epidermal peroxisome proliferator-activated receptor beta/delta expression dictate wound repair kinetics. J Biol Chem 280: 18163-18170.
13. Chong HC, Tan MJ, Philippe V, Tan SH, Tan CK, et al. (2009) Regulation of epithelial-mesenchymal IL-1 signaling by PPARbeta/delta is essential for skin homeostasis and wound healing. J Cell Biol 184: 817-831.
14. Kersten S, Mandard S, Tan NS, Escher P, Metzger D, et al. (2000) Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene. J Biol Chem 275: 28488-28493.
15. Oike Y, Akao M, Kubota Y, Suda T, (2005) Angiopoietin-like proteins: potential new targets for metabolic syndrome therapy. Trends Mol Med 11: 473-479.
16. Mandard S, Zandbergen F, van Straten E, Wahli W, Kuipers F, et al. (2006) The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity. J Biol Chem 281: 934-944.
17. Sukonina V, Lookene A, Olivecrona T, Olivecrona G, (2006) Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue. Proc Natl Acad Sci U S A 103: 17450-17455.
18. Lichtenstein L, Mattijssen F, de Wit NJ, Georgiadi A, Hooiveld GJ, et al. (2010) Angptl4 Protects against Severe Proinflammatory Effects of Saturated Fat by Inhibiting Fatty Acid Uptake into Mesenteric Lymph Node Macrophages. Cell Metab 12: 580-592.
19. Clement LC, Avila-Casado C, Macé C, Soria E, Bakker WW, et al. (2011) Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome. Nat Med 17: 117-122.
20. Zhu P, Tan MJ, Huang RL, Tan CK, Chong HC, et al. (2011) Angiopoietin-like 4 protein elevates the prosurvival intracellular O2(-):H2O2 ratio and confers anoikis resistance to tumors. Cancer Cell 19: 401-415.
21. Goh YY, Pal M, Chong HC, Zhu P, Tan MJ, et al. (2010) Angiopoietin-like 4 interacts with integrins beta1 and beta5 to modulate keratinocyte migration. Am J Pathol 177: 2791-2803.
22. Goh YY, Pal M, Chong HC, Zhu P, Tan MJ, et al. (2010) Angiopoietin-like 4 interacts with matrix proteins to modulate wound healing. J Biol Chem 285: 32999-33009.
23. Oliver WR, Shenk JL, Snaith MR, Russell CS, Plunket KD, et al. (2001) A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport. Proc Natl Acad Sci U S A 98: 5306-5311.
24. Mandard S, Zandbergen F, Tan NS, Escher P, Patsouris D, et al. (2004) The direct peroxisome proliferator-activated receptor target fasting-induced adipose factor (FIAF/PGAR/ANGPTL4) is present in blood plasma as a truncated protein that is increased by fenofibrate treatment. J Biol Chem 279: 34411-34420.
25. Köster A, Chao Y, Mosior M, Ford A, Gonzalez-DeWhitt P, (2005) Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl regulation of triglyceride metabolism. Endocrinology 146: 4943-4950.
26. Maas-Szabowski N, Szabowski A, Stark HJ, Andrecht S, Kolbus A, et al. (2001) Organotypic cocultures with genetically modified mouse fibroblasts as a tool to dissect molecular mechanisms regulating keratinocyte growth and differentiation. J Invest Dermatol 116: 816-820.
27. Shearer BG, Steger DJ, Way JM, Stanley TB, Lobe DC, et al. (2008) Identification and characterization of a selective peroxisome proliferator-activated receptor beta/delta (NR1C2) antagonist. Mol Endocrinol 22: 523-529.
28. Rutberg SE, Saez E, Glick A, Dlugosz AA, Spiegelman BM, et al. (1996) Differentiation of mouse keratinocytes is accompanied by PKC-dependent changes in AP-1 proteins. Oncogene 13: 167-176.
29. Kamioka N, Akahane T, Kohno Y, Kuroki T, Iijima M, et al. (2010) Protein kinase C delta and eta differently regulate the expression of loricrin and Jun family proteins in human keratinocytes. Biochem Biophys Res Commun 394: 106-111.
30. Schönwasser DC, Marais RM, Marshall CJ, Parker PJ, (1998) Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes. Mol Cell Biol 18: 790-798.
31. Schechtman D, Mochly-Rosen D, (2001) Adaptor proteins in protein kinase C-mediated signal transduction. Oncogene 20: 6339-6347.
32. Li H, Ge C, Zhao F, Yan M, Hu C, et al. (2011) HIF-1α-activated ANGPTL4 contributes to tumor metastasis via VCAM-1/integrin β1 signaling in human hepatocellular carcinoma. Hepatology 54: 910-919.
33. Stapleton CM, Joo JH, Kim YS, Liao G, Panettieri RA, et al. (2010) Induction of ANGPTL4 expression in human airway smooth muscle cells by PMA through activation of PKC and MAPK pathways. Exp Cell Res 316: 507-516.
34. Lei K, Nimnual A, Zong WX, Kennedy NJ, Flavell RA, et al. (2002) The Bax subfamily of Bcl2-related proteins is essential for apoptotic signal transduction by c-Jun NH(2)-terminal kinase. Mol Cell Biol 22: 4929-4942.
35. Bornstein P, Sage EH, (2002) Matricellular proteins: extracellular modulators of cell function. Curr Opin Cell Biol 14: 608-616.
36. Dutton S, Trayhurn P, (2008) Regulation of angiopoietin-like protein 4/fasting-induced adipose factor (Angptl4/FIAF) expression in mouse white adipose tissue and 3T3-L1 adipocytes. Br J Nutr 100: 18-26.
37. Ito Y, Oike Y, Yasunaga K, Hamada K, Miyata K, et al. (2003) Inhibition of angiogenesis and vascular leakiness by angiopoietin-related protein 4. Cancer Res 63: 6651-6657.
38. Cazes A, Galaup A, Chomel C, Bignon M, Bréchot N, et al. (2006) Extracellular matrix-bound angiopoietin-like 4 inhibits endothelial cell adhesion, migration, and sprouting and alters actin cytoskeleton. Circ Res 99: 1207-1215.
39. Gealekman O, Burkart A, Chouinard M, Nicoloro SM, Straubhaar J, et al. (2008) Enhanced angiogenesis in obesity and in response to PPARgamma activators through adipocyte VEGF and ANGPTL4 production. Am J Physiol Endocrinol Metab 295: E1056-E1064.
40. Tan SH, Pal M, Tan MJ, Wong MHL, Tam FU, et al. (2009) Regulation of Cell Proliferation and Migration by TAK1 via Transcriptional Control of von Hippel-Lindau Tumor Suppressor. J Biol Chem 284: 18047-18058.
41. Yeung YG, Stanley ER, (2009) A solution for stripping antibodies from polyvinylidene fluoride immunoblots for multiple reprobing. Anal Biochem 389: 89-91.